SCHEDULE: Parkman Healthcare Discloses 5.8% Stake in InspireMD

Parkman Healthcare Partners and related entities have reported a 5.8% beneficial ownership stake in InspireMD, Inc., totaling 2,440,633 shares.

Summary

• Parkman Healthcare Partners LLC, Parkman Healthcare Partners Holdings LP, Parkman Healthcare Partners Holdings GP LLC, and Gregory Martinez have jointly filed a Schedule 13G.
• The filing reports beneficial ownership of 2,440,633 shares of InspireMD, Inc. Common Stock, representing 5.8% of the class.
• The shares are held with shared voting and shared dispositive power among the reporting persons.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of InspireMD, Inc.
• The beneficial ownership event date was September 30, 2025.

Sentiment

Score: 5

Explanation: The filing is a standard beneficial ownership disclosure (Schedule 13G) and is largely neutral in sentiment, reporting a factual ownership stake without commentary on company performance or future prospects. The presence of an institutional investor can be seen as a minor positive.

Positives

• The disclosure of a significant institutional ownership stake by Parkman Healthcare Partners may signal confidence in InspireMD, Inc. from a specialized healthcare investor.

Negatives

• The filing does not contain any negative financial or operational information about InspireMD, Inc.

Risks

• The filing does not explicitly mention specific risks related to InspireMD, Inc. beyond the general market risks inherent in holding common stock.

Future Outlook

The filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding InspireMD, Inc.'s future performance or operations.

Management Comments

• Gregory Martinez, Managing Member of Parkman Healthcare Partners LLC, Parkman Healthcare Partners Holdings LP, and Parkman Healthcare Partners Holdings GP LLC, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Industry Context

This filing indicates an investment by a healthcare-focused firm, Parkman Healthcare Partners, in InspireMD, Inc., a company operating in the medical device sector. Such institutional investments are common and reflect investor interest in specific companies within the broader healthcare industry.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor holding 5.8% of the common stock may be viewed positively, indicating institutional confidence and potentially increasing liquidity or stability in the stock.

Key Dates

Keywords

InspireMD, Parkman Healthcare Partners, Schedule 13G, Beneficial Ownership, Common Stock, Healthcare Investment, Institutional Ownership, Medical Devices